ACT-777991
ACT-777991 is a selective, orally bioavailable CXCR3 antagonist that demonstrates metabolic stability in preclinical models. It potently blocks CXCL11-mediated T cell migration, making it a valuable research tool for investigating inflammatory and autoimmune diseases in both in vitro and in vivo experimental settings.
Product Specifications
CAS Number
1967811-46-6
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Smiles
C (F) (F) (F) C=1SC (=C (N1) C=2C=NC (C (F) (F) F) =NC2) N3C[C@@H] (CCO) N (C (CN4N=C (C) N=C4) =O) CC3
Molecular Formula
C20H20F6N8O2S
Molecular Weight
550.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472714-500 1x 500 µL
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker) (CPA1/2714), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB1462-100 1x 100 µL
NSE gamma (Neuron Specific Enolase, gamma) (Neuroendocrine Marker) (ENO2/1462), 0.2mg/mL
Sign In for Pricing
View Details